Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Commentary
  • Published:

News & Commentary

Aβ peptide deposition in the brains of transgenic mice: evidence for a key event in Alzheimer's disease pathogenesis

Molecular Psychiatry volume 3, pages 284–286 (1998)Cite this article

Abstract

Transgenic technology has led to the generation of several animal models for Alzheimer's disease. These transgenic mice surprisingly reproduce many aspects of the pathological alterations observed in Alzheimer's disease patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Nervous System Research, Novartis Pharma Inc, Basel, CH-4002, Switzerland

    B Sommer & M Staufenbiel

Authors
  1. B Sommer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Staufenbiel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sommer, B., Staufenbiel, M. Aβ peptide deposition in the brains of transgenic mice: evidence for a key event in Alzheimer's disease pathogenesis. Mol Psychiatry 3, 284–286 (1998). https://doi.org/10.1038/sj.mp.4000397

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000397

Search

Advanced search

Quick links